A Structured Exercise Program for Patients with Advanced Non-small Cell Lung Cancer

被引:139
|
作者
Temel, Jennifer S. [1 ]
Greer, Joseph A. [1 ]
Goldberg, Sarah [1 ]
Vogel, Paula Downes [1 ]
Sullivan, Michael [1 ]
Pirl, William F. [1 ]
Lynch, Thomas J. [1 ]
Christiani, David C. [1 ]
Smith, Matthew R. [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
Non-small cell lung cancer; Exercise; Supportive care; QUALITY-OF-LIFE; HIGH-DOSE CHEMOTHERAPY; PHYSICAL-ACTIVITY; BREAST-CANCER; FUNCTIONAL ASSESSMENT; MEGESTROL-ACETATE; AEROBIC EXERCISE; OUTPATIENT REHABILITATION; PULMONARY REHABILITATION; RESISTANCE EXERCISE;
D O I
10.1097/JTO.0b013e31819d18e5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Exercise improves functional outcome and symptoms for certain cancer populations, but the feasibility, efficacy, and safety of structured exercise in patients with lung cancer is unknown. In this Study, we examined the feasibility of a hospital-based exercise program for patients with advanced non-small cell lung cancer. Methods: This study included patients with newly diagnosed advanced stage non-small cell lung cancer and Eastern Cooperative Oncology Group performance status 0-1. A physical therapist facilitated twice-weekly sessions of aerobic exercise and weight training over an 8-week period. The primary end point was feasibility of the intervention, defined as adherence to the exercise program. Secondary endpoints included functional capacity, measured by the 6-minute walk test and Muscle strength, as well as quality Of life, lung cancer symptoms and fatigue, measured by the Functional Assessment of Cancer Therapy-lung and Functional Assessment of Cancer Therapy-fatigue scales. Results: Between October 2004 and August 2007, 25 patients enrolled in the study. All participants received anticancer therapy during the Study period. Twenty patients (80%) underwent the baseline physical therapy evaluation. Eleven patients (44%) completed all 16 sessions. An additional 6 patients attended at least 6 sessions (range, 6-15), and 2 patients only attended one session. Study completers experienced a significant reduction in lung cancer symptoms and no deterioration in their 6-minute walk test or muscle strength. Conclusions: Although the majority of participants attempted the exercise program, less than half were able to complete the intervention. Those who completed the program experienced an improvement in their lung cancer symptoms. Community-based or briefer exercise interventions may be more feasible in this population.
引用
收藏
页码:595 / 601
页数:7
相关论文
共 50 条
  • [21] Physical activity in patients with non-small cell lung cancer after lung resection
    Yanagita, Yorihide
    Arizono, Shinichi
    Tawara, Yuichi
    Oomagari, Masaki
    Machiguchi, Hikaru
    Tanahashi, Masayuki
    Katagiri, Norimasa
    Iida, Yuki
    Kozu, Ryo
    CLINICAL BIOMECHANICS, 2024, 115
  • [22] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    BMC Cancer, 14 (1)
  • [23] Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer
    Avancini, Alice
    Borsati, Anita
    Trestini, Ilaria
    Tregnago, Daniela
    Belluomini, Lorenzo
    Sposito, Marco
    Rota, Michele
    Insolda, Jessica
    Schena, Federico
    Milella, Michele
    Pilotto, Sara
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2023, 10
  • [24] Chemotherapy for Advanced-Stage Non-Small Cell Lung Cancer
    Du, Lingling
    Morgensztern, Daniel
    CANCER JOURNAL, 2015, 21 (05) : 366 - 370
  • [25] Maintenance therapy in advanced non-small cell lung cancer in 2012
    Perol, M.
    ONCOLOGIE, 2012, 14 (05) : 297 - 304
  • [26] Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy
    Hwang, Chueh-Lung
    Yu, Chong-Jen
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    Wu, Ying-Tai
    SUPPORTIVE CARE IN CANCER, 2012, 20 (12) : 3169 - 3177
  • [27] Ramucirumab for the treatment of advanced or metastatic non-small cell lung cancer
    Takeda, Koji
    Daga, Haruko
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (12) : 1541 - 1547
  • [28] Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
    Kimura, Madoka
    Naito, Tateaki
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Wakuda, Kazushige
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Mori, Keita
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    SUPPORTIVE CARE IN CANCER, 2015, 23 (06) : 1699 - 1708
  • [29] Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer
    Se Hoon Park
    Seong Hwan Jeong
    Sun Young Kyung
    Young-Hee Lim
    Chang Hyeok An
    Sang Pyo Lee
    Jeong Woong Park
    Soo Mee Bang
    Eun Kyung Cho
    Dong Bok Shin
    Jae Hoon Lee
    Medical Oncology, 2005, 22 : 359 - 366
  • [30] Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer
    Harper, P
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 2 - 12